AAAAAA

   
Results: 1-8 |
Results: 8
Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors
Authors: Doolittle, ND Muldoon, LL Brummett, RE Tyson, RM Lacy, C Bubalo, JS Kraemer, DF Heinrich, MC Henry, JA Neuwelt, EA
Citation: Nd. Doolittle et al., Delayed sodium thiosulfate as an otoprotectant against carboplatin-inducedhearing loss in patients with malignant brain tumors, CLIN CANC R, 7(3), 2001, pp. 493-500
Combined intraarterial carboplatin, intraarterial etoposide phosphate, andIV cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children
Authors: Osztie, E Varallyay, P Doolittle, ND Lacy, C Jones, G Nickolson, HS Neuwelt, EA
Citation: E. Osztie et al., Combined intraarterial carboplatin, intraarterial etoposide phosphate, andIV cytoxan chemotherapy for progressive optic-hypothalamic gliomas in young children, AM J NEUROR, 22(5), 2001, pp. 818-823
Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (Human non-acquired immunodeficiency syndrome) and survival
Authors: Kraemer, DF Fortin, D Doolittle, ND Neuwelt, EA
Citation: Df. Kraemer et al., Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (Human non-acquired immunodeficiency syndrome) and survival, NEUROSURGER, 48(5), 2001, pp. 1033-1040
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity
Authors: Muldoon, LL Pagel, MA Kroll, RA Brummett, RE Doolittle, ND Zuhowski, EG Egorin, MJ Neuwelt, EA
Citation: Ll. Muldoon et al., Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity, CLIN CANC R, 6(1), 2000, pp. 309-315
Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma
Authors: McAllister, LD Doolittle, ND Guastadisegni, PE Kraemer, DF Lacy, CA Crossen, JR Neuwelt, EA
Citation: Ld. Mcallister et al., Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma, NEUROSURGER, 46(1), 2000, pp. 51-60
Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors
Authors: Doolittle, ND Miner, ME Hall, WA Siegal, T Hanson, EJ Osztie, E McAllister, LD Bubalo, JS Kraemer, DF Fortin, D Nixon, R Muldoon, LL Neuwelt, EA
Citation: Nd. Doolittle et al., Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors, CANCER, 88(3), 2000, pp. 637-647
Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruptionin the vertebral artery
Authors: Fortin, D McAllister, LD Nesbit, G Doolittle, ND Miner, M Hanson, EJ Neuwelt, EA
Citation: D. Fortin et al., Unusual cervical spinal cord toxicity associated with intra-arterial carboplatin, intra-arterial or intravenous etoposide phosphate, and intravenous cyclophosphamide in conjunction with osmotic blood brain-barrier disruptionin the vertebral artery, AM J NEUROR, 20(10), 1999, pp. 1794-1802
Cerebrovascular biology and the various neural barriers: Challenges and future directions
Authors: Neuwelt, EA Abbott, NJ Drewes, L Smith, QR Couraud, PO Chiocca, EA Audus, KL Greig, NH Doolittle, ND
Citation: Ea. Neuwelt et al., Cerebrovascular biology and the various neural barriers: Challenges and future directions, NEUROSURGER, 44(3), 1999, pp. 604-608
Risultati: 1-8 |